Results summary | View all lists in L2L MDB | View all genes in P01B.profile.ud50 |
Up-regulated at 6 hr following treatment of peripheral blood mononuclear cells (PBMC) with BAY 50-4798, an IL-2 receptor agonist. enrichment: 3.83-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
221563_AT | DUSP10 | X | P | S | dual specificity phosphatase 10 | ||||||||
204058_AT | ME1 | E | malic enzyme 1, NADP(+)-dependent, cytosolic | ||||||||||
221750_AT | HMGCS1 | E | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) | ||||||||||
217678_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
201627_S_AT | INSIG1 | G | insulin induced gene 1 | ||||||||||
201468_S_AT | NQO1 | X | E | C | NAD(P)H dehydrogenase, quinone 1 | ||||||||
203925_AT | GCLM | X | E | glutamate-cysteine ligase, modifier subunit | |||||||||
209146_AT | SC4MOL | E | sterol-C4-methyl oxidase-like | ||||||||||
202679_AT | NPC1 | T | E | Nasopharyngeal carcinoma 1 |